Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06889831 · ClinicalTrials.gov registry record · NA

WORTH Paths Intervention

A NA study of Substance Use Disorder (SUD) and Sexual Risk Behavior, sponsored by Fairleigh Dickinson University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06889831 is a NA study of Substance Use Disorder (SUD) and Sexual Risk Behavior that is actively recruiting participants, run by Fairleigh Dickinson University. The registered enrollment target is 50 participants, below the 246-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06889831, a NA study of Substance Use Disorder (SUD) and Sexual Risk Behavior, is actively recruiting participants, sponsored by Fairleigh Dickinson University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Women in the criminal legal system are more likely to experience substance use disorders and unintended pregnancy than women in the general public. However, they often face barriers to accessing substance use treatment and sexual and reproductive health services. This study tests the feasibility and acceptability of Women on the Road to Health (WORTH) Promoting Access to Treatment, Health, and Support (Paths), a digital intervention adapted from the evidence-based CDC Best Practice HIV prevention intervention, Women on the Road to Health (WORTH), originally developed at Columbia University School of Social Work. WORTH Paths is designed to help reproductive-aged women in the criminal legal system with substance use disorders and unmet need for contraception reduce drug use and improve contraceptive use. Participants (N=50) will be randomly assigned to one of two groups: WORTH Paths Intervention Group - Participants will attend three virtual group sessions with facilitated videoconference sessions and self-paced digital activities focused on reducing drug use and increasing contraceptive use. They will also receive guidance on how to access and navigate health services. Control Group - Participants will receive a virtual general wellness program that includes education on substance use and sexual and reproductive health but does not include skills-based training related to these topics. The focus will be on general wellness and stress reduction. Both groups will receive resources for substance use treatment and sexual and reproductive health services. Researchers will track changes in drug use and contraceptive use over three months. Participants will complete surveys and provide urine samples to confirm changes in drug use. Primary aims: Feasibility: Measured by session attendance, treatment completion, dropouts, and reasons for termination. Acceptability: Measured by participant ease of use, helpfulness, and satisfaction. Primary behavioral outcomes: Self

Interventions

  • BEHAVIORAL WORTH Paths Digital Intervention
  • BEHAVIORAL WORTH Paths Wellness Group

Study Locations (1)

New Jersey

  • Fairleigh Dickinson University - Teaneck

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-08-12
Est. Completion 2026-04-01
Phase NA

Sponsor

Fairleigh Dickinson University

1 total trials

What the Registry Record Tells You About NCT06889831

The ClinicalTrials.gov registry entry for NCT06889831 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 246-participant average among 15 other Substance Use Disorder (SUD) trials with a reported enrollment target (80% lower). The listed sponsor is Fairleigh Dickinson University, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Substance Use Disorder (SUD) appearing as the primary indexed condition, and to 2 interventions - of which WORTH Paths Digital Intervention is the first listed.

NCT06889831 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06889831 about?

NCT06889831 is a clinical study titled "WORTH Paths Intervention". Women in the criminal legal system are more likely to experience substance use disorders and unintended pregnancy than women in the general public. However, they often face barriers to accessing substance use treatment and sexual and reproductive health services. This study tests the feasibility an...

What is the current status of trial NCT06889831?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-12. Estimated completion is 2026-04-01.

What conditions does trial NCT06889831 study?

This clinical trial studies the following conditions: Substance Use Disorder (SUD), Sexual Risk Behavior, Sexual and Reproductive Health.

What interventions are being tested in trial NCT06889831?

The interventions under investigation include: WORTH Paths Digital Intervention (BEHAVIORAL), WORTH Paths Wellness Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06889831?

This trial is sponsored by Fairleigh Dickinson University, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06889831 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorder (SUD)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.